| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.22B | 46.74B | 41.98B | 41.36B | 38.63B | 37.24B |
| Gross Profit | 12.34B | 14.25B | 12.65B | 13.16B | 12.24B | 11.22B |
| EBITDA | 3.15B | 4.53B | 3.41B | 3.99B | 3.75B | 3.88B |
| Net Income | 951.52M | 4.11B | 1.20B | 1.48B | 1.67B | 2.19B |
Balance Sheet | ||||||
| Total Assets | 46.71B | 48.05B | 47.01B | 47.83B | 43.63B | 40.54B |
| Cash, Cash Equivalents and Short-Term Investments | 6.91B | 8.53B | 6.53B | 8.88B | 6.60B | 6.66B |
| Total Debt | 10.06B | 4.87B | 9.64B | 11.45B | 9.18B | 8.61B |
| Total Liabilities | 21.58B | 20.93B | 20.88B | 22.51B | 19.04B | 17.38B |
| Stockholders Equity | 24.50B | 26.37B | 25.44B | 24.73B | 23.73B | 22.34B |
Cash Flow | ||||||
| Free Cash Flow | -45.76M | 3.21B | 1.12B | 1.92B | 784.70M | 2.50B |
| Operating Cash Flow | 85.64M | 4.06B | 1.71B | 2.63B | 1.86B | 3.14B |
| Investing Cash Flow | -1.01B | 5.79B | -410.03M | -1.77B | -1.87B | -1.55B |
| Financing Cash Flow | -1.06B | -7.95B | -3.38B | 1.12B | -517.24M | -900.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥53.74B | 7.50 | ― | 3.25% | 11.34% | 257.59% | |
74 Outperform | ¥202.85B | 5.88 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥55.32B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
67 Neutral | ¥21.59B | 15.35 | ― | 3.83% | 21.81% | -49.75% | |
64 Neutral | ¥40.20B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥47.44B | 32.39 | 1.55% | 1.34% | -14.56% | 181.24% |